ABVC BioPharma closes senior convertible note offering, raising $3.39 million
ABVC•ABVC BioPharma raised approximately $3.39 million gross in a private placement of senior convertible notes with $4.11 million in aggregate principal.
1. Offering terms
The notes carry a 17.5% original issue discount and mature on June 30, 2027. Net proceeds will support working capital and subsidiaries, and fund a $625,000 settlement payment to Lind Global Fund II LP.
